Search Ansar

A calm view of what changed in startups. One development shown once, with its evidence attached. Free, with no ads, no paid tier and no paid ranking.

Read

What changed
Explore
Trends
Companies

Understand

How this works
Sources and licences

Yours

Following
Settings

Every fact on Ansar links back to where it came from.

AppearanceLightDarkSystem

270 Life Sciences Private Capital Fund Ii (Cayman) LP filed an exempt offering notice (Form D) · Ansar News

Home / 270 Life Sciences Private Capital Fund Ii (Cayman) LP

2270 Life Sciences Private Capital Fund Ii (Cayman) LPSecurities offering1d ago

270 Life Sciences Private Capital Fund Ii (Cayman) LP filed an exempt offering notice (Form D)

What happened

270 Life Sciences Private Capital Fund Ii (Cayman) LP filed a Form D with the SEC — the notice filed after selling securities in an exempt offering. The filing does not state a round size, and Ansar does not infer one.

Evidence

1 independent

SEC EDGARfirst to reportseen 1h ago

https://www.sec.gov/Archives/edgar/data/2154213/0002154213-26-000001.txt

At a glance

Confidence

69%

Significance

57%

Sources

1 independent

Collected

1h ago

happened 1d ago

Model-derived signals

Computed by Ansar

Confidence69%

Strongest verification behind this event, aged, and discounted by how sure we are it belongs to this company.

Ecosystem significance57%

How much this moves the ecosystem, independent of your interests.

Promotional language0%

Share of marketing vocabulary detected in the headline and summary.

Concrete detail1

Distinct kinds of checkable fact found: amounts, versions, measured changes.

These are Ansar’s estimates, not source claims. The summary was assembled from source text, not generated.

Company

2270 Life Sciences Private Capital Fund Ii (Cayman) LP

Full timeline